Coulter Articles & Analysis
5 news found
Beckman Coulter, a global clinical diagnostics leader, announces it will introduce new antipsychotic drug tests to laboratories and clinicians to address an unmet clinical need for 69 million people with serious mental conditions worldwide. ...
He also served as Chief Financial Officer of Miraval Holding, Q3DM (acquired by Beckman Coulter), Medication Delivery Devices (acquired by Baxter Healthcare) and was a Principal at Ventana Growth Funds, an international venture capital firm. ...
We are happy to announce that RAMCON will be adding the clinical diagnostics solutions from Beckman Coulter to our product portfolio, starting January 1 2021! RAMCON has been a long time Beckman Coulter partner, and we are pleased to consolidate our business relationship even further. We are looking forward to bring our high level of knowledge and experience in ...
ByRAMCON
The licensed research was supported in part by the National Institutes of Health and the Coulter Translational Research Partners II Program at the University of Pittsburgh. ...
"The approval of the ABBOTT PRISM Chagas test marks the availability of an important automated tool to ensure the continued safety of our blood supply, and it also offers our customers the ability to conduct all their serology testing on one system to increase the productivity and efficiency of their labs," said John Coulter, divisional vice president, U.S. commercial operations, ...